{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Method of inhibiting hepatic fibrosis as a result of liver replacement or repair using A2B adenosine receptor antagonists", "item": "https://www.patentleaderboard.com/patent/8609671"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of inhibiting hepatic fibrosis as a result of liver replacement or repair using A2B adenosine receptor antagonists

Method of inhibiting hepatic fibrosis as a result of liver replacement or repair using A2B adenosine receptor antagonists

US Patent 8609671 · Granted Dec 17, 2013

Estimated economic value: $625,910,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Kits and methods for induction of cardioversion in subjects with atrial arrhythm2024
Antiarrhythmic formulation2021
Antiarrhythmic formulation2021
Method to slow ventricular rate2020
Combining electronic monitoring with inhaled pharmacological therapy to manage c2020
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmona2019
2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists2019
Combining electronic monitoring with inhaled pharmacological therapy to manage c2018
Compositions and methods of treating pulmonary hypertension2017
Myocardial perfusion imaging methods and compositions2016
Methods of myocardial perfusion imaging2015
Methods of treating hypertrophic cardiomyopathy2015